dimethyl 4-hydroxy-5-methoxyphthalate | 50522-17-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: dimethyl 4-hydroxy-5-methoxyphthalate
• 英文别名: 4-hydroxy-5-methoxy-phthalic acid dimethyl ester；4-Hydroxy-5-methoxy-phthalsaeure-dimethylester；dimethyl 4-hydroxy-5-methoxybenzene-1,2-dicarboxylate
• CAS: 50522-17-3
• 化学式: C₁₁H₁₂O₆
• 分子量: 240.213
• InChiKey: JOPAQXGIQZVEPQ-UHFFFAOYSA-N

物化性质

• 熔点：
  93-94 °C
• 沸点：
  376.8±37.0 °C(Predicted)
• 密度：
  1.280±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  82.1
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  dimethyl 4-hydroxy-5-methoxyphthalate 在 吡啶 、 titanium(IV) isopropylate 、 甲醇 、 偶氮二甲酸二异丙酯 、 三乙酰氧基硼氢化钠 、 sodium cyanoborohydride 、 三苯基膦 、 三氟乙酸 、 lithium iodide 作用下， 以 四氢呋喃 、 二氯甲烷 、 异丙醇 为溶剂， 反应 11.0h， 生成 2-(2,6-dioxopiperidin-3-yl)-5-((1r,3r)-3-(isopropyl(piperidin-4-ylmethyl)amino)cyclobutoxy)-6-methoxyisoindoline-1,3-dione
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN
  [FR] COMPOSÉS ET PROCÉDÉS POUR LA DÉGRADATION CIBLÉE DE PROTÉINE DU RÉCEPTEUR DES ANDROGÈNES

  摘要：

  本文描述了具有雄激素受体（AR）调节剂作用的双功能化合物。特别是，本公开的双功能化合物在一端含有结合到cereblon E3泛素连接酶的基团，在另一端含有结合到AR的基团，使得目标蛋白质靠近泛素连接酶以降解（和抑制）目标蛋白质。本公开的双功能化合物表现出与目标蛋白质降解/抑制相关的广泛的药理活性。使用本公开的化合物和组合物治疗或预防由于目标蛋白质异常调节而导致的疾病或障碍。

  公开号：

  WO2022087125A1
• 作为产物：
  描述：

  4,5-二甲氧基邻苯二甲酸 在 盐酸 、 硫酸 作用下， 生成 dimethyl 4-hydroxy-5-methoxyphthalate
  参考文献：
  名称：

  Aiding chronic written language expression difficulties: A case study

  摘要：

  This paper describes some progress made in helping a young aphasic man (MD) to overcome what had appeared to be intractable written language expression difficulties, which continued to be significant for him. Traditional therapy methods based on cognitive neuropsychological assessment had failed to help MD to generalize improvement in his spelling particularly, but not exclusively, of longer and irregular words. Both a splint which allowed him to use his dominant hand for writing directly onto a computer screen and a simple word-processing programme with synthesized auditory feedback and lexical and grammatical prediction (Write:OutLoud(R) and Co:Writer(R)) enabled him to produce more normal written output (increased quantity and more normal quality). The discussion also focuses on how effectiveness of language therapy can be measured in this man with chronic aphasia.

  DOI：

  10.1080/026870300401612

文献信息

• HETEROCYCLIC AMIDE COMPOUNDS AS PROTEIN KINASE INHIBITORS
  申请人：Reddy Panduranga Adulla P.

  公开号：US20100286135A1

  公开（公告）日：2010-11-11

  The present invention relates to novel heterocyclic amide compounds of Formula I: as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are compositions comprising said compounds, and methods for using said compounds for treating or preventing a proliferative disease, an anti-proliferative disorder, inflammation, arthritis, a neurological or neurodegenerative disease, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease or a fungal disease.

  本发明涉及公式I的新异环酰胺化合物，如本文所述或其药学上可接受的盐、溶剂化物、酯、前药或立体异构体。还公开了包含该化合物的组合物，并且公开了使用该化合物治疗或预防增殖性疾病、抗增殖性障碍、炎症、关节炎、神经或神经退行性疾病、心血管疾病、脱发、神经元疾病、缺血性损伤、病毒性疾病或真菌病的方法。
• US8293747B2
  申请人：——

  公开号：US8293747B2

  公开（公告）日：2012-10-23
• Aiding chronic written language expression difficulties: A case study
  作者：Linda Armstrong、Alison Macdonald

  DOI：10.1080/026870300401612

  日期：2000.1

  This paper describes some progress made in helping a young aphasic man (MD) to overcome what had appeared to be intractable written language expression difficulties, which continued to be significant for him. Traditional therapy methods based on cognitive neuropsychological assessment had failed to help MD to generalize improvement in his spelling particularly, but not exclusively, of longer and irregular words. Both a splint which allowed him to use his dominant hand for writing directly onto a computer screen and a simple word-processing programme with synthesized auditory feedback and lexical and grammatical prediction (Write:OutLoud(R) and Co:Writer(R)) enabled him to produce more normal written output (increased quantity and more normal quality). The discussion also focuses on how effectiveness of language therapy can be measured in this man with chronic aphasia.
• [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LA DÉGRADATION CIBLÉE DE PROTÉINE DU RÉCEPTEUR DES ANDROGÈNES
  申请人：ARVINAS OPERATIONS INC

  公开号：WO2022087125A1

  公开（公告）日：2022-04-28

  Bifunctional compounds, which find utility as modulators of androgen receptor (AR), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds AR, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本文描述了具有雄激素受体（AR）调节剂作用的双功能化合物。特别是，本公开的双功能化合物在一端含有结合到cereblon E3泛素连接酶的基团，在另一端含有结合到AR的基团，使得目标蛋白质靠近泛素连接酶以降解（和抑制）目标蛋白质。本公开的双功能化合物表现出与目标蛋白质降解/抑制相关的广泛的药理活性。使用本公开的化合物和组合物治疗或预防由于目标蛋白质异常调节而导致的疾病或障碍。